RT Journal Article
SR Electronic
T1 Freeze dried cryoprecipitate: a clinical evaluation.
JF Journal of Clinical Pathology
JO J Clin Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP 574
OP 576
DO 10.1136/jcp.36.5.574
VO 36
IS 5
A1 Hambley, H
A1 Davidson, J F
A1 Walker, I D
A1 Small, M
A1 Prentice, C R
YR 1983
UL http://jcp.bmj.com/content/36/5/574.abstract
AB Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.